Pioneering the Next Breakthrough in Durable and Potent RNA Therapeutics for Patients The field of next generation RNA therapeutics continues to progress towards clinical...

The development of mono- and bivalent degraders continues to gain traction, but biopharma faces challenges in rapidly discovering, validating, and utilizing novel E3 ligases....